FDA Investigator Andre S Lamontagne
Andre S Lamontagne has inspections in 8 countries as of 08 Sep 2023. Andre S Lamontagne has collaborated with a combined 625 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
68
Last Inspection Date:
08 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
China,
Taiwan,
Thailand,
Japan,
United States of America,
Malaysia,
Sweden
Co-Investigator(s):
Amber G Wardwell,
Brenda P King,
Camerson E Moore,
Darin S Wiegers,
David P Vanhouten,
Dawn M Braswell,
Elizabeth B Griffin,
Emir Galevi,
Francis J Eng,
Francis Pham,
George T Allen, Jr,
Gregory M Bessette,
Guozhou Mo,
Jonathan G Matrisciano,
Joseph C Teixeira,
Justina O Tam,
Justine M Corson,
Kayla R Huffman,
Lauren M Lawrance,
Laurie B Frazier,
Lisa D Cash,
Mark K Tseng,
Max Lager,
Michael P Sweeney,
Nabil Nakhoul,
Nassim Ben Makhlouf,
Paraluman S Leonin,
Paul P Geraci,
Richard H Penta,
Robert Mo Brien,
Sara M Onyango,
Seth A Mailhot,
Stacey S Degarmo,
Stephen C Smith,
Sunita Pandey,
Suzanne M Healy,
Terry C Kimball
Andre S Lamontagne's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2003 | FDA 483 | Cogentix Medical LLC - Form 483, 2003-07-11 |
July, 2003 | EIR | Cogentix Medical LLC - EIR, 2003-07-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more